Analysis of Wilms' tumor protein 1 specific TCR repertoire in AML patients uncovers higher diversity in patients in remission than in relapsed
Sofie Gielis, Donovan Flumens, Sanne van der Heijden, Maarten Versteven, Hans De Reu, Esther Bartholomeus, Jolien Schippers, Diana Campillo-Davó, Zwi Nisan Berneman, Sébastien Anguille, Evelien Smits, Benson Ogunjimi, Eva Lion, Kris Laukens, Pieter Meysman
The paper develops computational models to identify WT1-specific TCRs in AML patients and finds higher TCR diversity in remission compared to relapsed patients.
Annals of Hematology · Sep 11, 2024Peer-reviewedBioinformatics